Sign up to save your podcasts
Or
Share Obesity Medicine: New Therapies Transform Treatment, Yet Challenges Remain
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Obesity Medicine: New Therapies Transform Treatment, Yet Challenges Remain
During our second annual BMO Obesity Summit in New York, Evan Seigerman, Managing Director and Senior Research Analyst at BMO Capital Markets and Malcom Hoffman, Senior Equity Research Associate of BioPharma at BMO Capital Markets, sat down with Katherine Saunders, M.D., Obesity Physician and Co-Founder of FlyteHealth to reflect on the transformation of obesity medicine throughout the past year.
View all episodes
By BMO
4.8
88 ratings
During our second annual BMO Obesity Summit in New York, Evan Seigerman, Managing Director and Senior Research Analyst at BMO Capital Markets and Malcom Hoffman, Senior Equity Research Associate of BioPharma at BMO Capital Markets, sat down with Katherine Saunders, M.D., Obesity Physician and Co-Founder of FlyteHealth to reflect on the transformation of obesity medicine throughout the past year.
More shows like Markets Plus
View all
Exchanges
977 Listeners
Better conversations. Better outcomes. | Presented by BMO Global Asset Management
66 Listeners
Bold(h)er
2 Listeners
Macro Horizons
81 Listeners
Sustainability Leaders
22 Listeners
Thoughts on the Market
1,320 Listeners
BMO Equity Research IN Tune
6 Listeners
BMO Views from the North
3 Listeners
Global Exchanges
1 Listeners
Unhedged
194 Listeners